Authors: van den Bemd, Gert-Jan C.M.; Pols, Huibert A.P.; van Leeuwen, Johannes P.T.M.

Source: Current Drug Metabolism, Volume 6, Number 7, May 2000 , pp. 717-732(16)

Publisher: Bentham Science Publishers

Abstract:

The role of 1,25-dihydroxyvitamin D 3 (1,25-(OH)2 D 3 ) as a regulator of cell growth and differentiation is well recognized. Currently, 1,25-(OH)2 D 3 and vitamin D analogs are being evaluated for their therapeutic potential in the treatment of hyperproliferative disorders like cancer. In the present review, we will discuss several processes that might be involved in 1,25-(OH)2 D 3 - and vitamin D analog-mediated suppression of cancer cell growth. The effects on tumor cell proliferation, differentiation, apoptosis, angiogenesis, metastases, and parathyroid hormone-related peptide secretion will be highlighted. In addition, combination therapy with other tumor effective drugs will be addressed. Furtermore, we will focus on the potential drawbacks and the possible side effects of vitamin D compounds in the treatment of cancer.

Keywords: Anti Tumor; 1 25 Dihydroxyvitamin D3; Vitamin D Analogs; Cancer; Breast Carcinoma; Myeloid leukemia; Cervical Carcinoma; Osteosarcoma; Colon carcinoma; Ovarian carcinoma; Colorectal carcinoma/kwd>Pancreatic carcinoma; Fibrosarcoma; Pituitary Adenoma; Gall Bladder carcinoma; Prostate carcinoma; Intestine carcinoma; Renal cell carcinoma; Lung carcinoma; Squamous cell carcinoma; Lymphocytic leukemia; Transitional bladder carcinoma; Melanoma; Thyroid carcinoma; Medullary thyroid carcinoma; Uterine carcinosarcoma; Reduced angiogenesis; Tumor suppression; Reduction of metastases; Cell proliferation; Apoptosis; Cell differentiation; Angiogenesis; Parathyroid hormone related peptide PTH rP; Metasaes; Growth factor; Osteosarcoma human; Prostate human; Melanoma human; erythroleukemia cell line K 562; Parathyroid Hormone Related Peptide Secretion; Metastasis; cadherins fibronectin VCAM 1; Vitamin D Resistance; 22 Oxo 1 25 dihydroxyvitamin D3; Transforming growth factor

Document Type: Research article

Affiliations: 1: Department of Internal Medicine, Erasmus Medical Center Rotterdam, PO BOX 1738, 3000 DR Rotterdam, The Netherland

Publication date: 2000-05-01

More about this publication?

• Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.
  
  Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Related content

• In this: publication
• By this: publisher
• In this Subject: Pharmacology
• By this author: van den Bemd, Gert-Jan C.M. ;  Pols, Huibert A.P. ;  van Leeuwen, Johannes P.T.M.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers